Clinical trial
Phase I Study of Adoptive Transfer of Autologous T Lymphocytes Engrafted With a Chimeric Antigen Receptor Targeting the Kappa Light Chain of Immunoglobulin Expressed in Patients With CLL, B-Cell Lymphoma or Multiple Myeloma
NCT00881920 is registered in ClinicalTrials.gov with Baylor College of Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase I Study of Adoptive Transfer of Autologous T Lymphocytes Engrafted With a Chimeric Antigen Receptor Targeting the Kappa Light Chain of Immunoglobulin Expressed in Patients With CLL, B-Cell Lymphoma or Multiple Myeloma
- Lead sponsor
- Baylor College of Medicine
- Phase
- Phase 1
- Overall status
- Active, not recruiting
- Start date
- July 31, 2009
- Completion date
- July 31, 2035
- Enrollment
- 54 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.